Document text
Principal Investigator: RICHARD G WUNDERINK
Organization: NORTHWESTERN UNIVERSITY AT CHICAGO
Fiscal Year: 2024
Award: $229,472
Funding agency: National Heart Lung and Blood Institute
PROJECT SUMMARY CORE B
Lower respiratory tract infections cause nearly 80% of deaths from infectious diseases in the US, and respiratory
viruses, such as influenza and SARS-CoV-2, are increasingly recognized as common causes of severe
community-acquired pneumonia (CAP). As mortality from severe CAP persists despite appropriate
antimicrobial treatment and clearance of the causative pathogen, Program Project Investigators hypothesize
that mortality and persistent organ failure in severe viral CAP represent persistent inflammatory injury and a
failure of lung repair mechanisms. Persistent inflammation and unrepaired organ damage drive poor long-term
outcomes following severe CAP, and biomarkers suggest that patients with poor outcomes from severe CAP
have a persistent pro-inflammatory state despite clearance of the presumed pathogen. Core B will allow Project
Investigators to validate findings from causal murine and cell models of influenza pneumonia in patients with
severe CAP induced by viral pathogens. The major goal of Core B is to provide serial bronchoalveolar
lavage (BAL) samples obtained from well-phenotyped patients with severe influenza and SARS-CoV-2
pneumonia to the Project Investigators, as defined in the following Specific Aims: 1) Provide BAL fluid
from intubated patients with influenza and SARS-CoV-2 pneumonia for a) flow cytometry-sorted BAL alveolar
immune cell subsets for transcriptomic and epigenomic analysis and b) cell-free supernatant fluid for
metabolomic and biomarker/protein analyses. 2) Define the microbiologic milieu at each BAL sampling time
point regarding a) the presence of viral pathogens (viral PCR), b) the presence of bacterial co-infection (culture
and PCR), and c) microbiome alterations. 3) Apply robust clinical phenotypes and relevant clinical endpoints.
Core B will leverage the existing infrastructure of the Successful Clinical Response In Pneumonia Therapy
(SCRIPT) Systems Biology Center at Northwestern University and its rigorous published protocols for flow
cytometry sorting of alveolar immune cell populations, microbiologic analysis, and clinical phenotyping.
Ultimately, the goal of this PPG is to define immune system pathways and mechanisms of failed resolution and
repair following influenza and SARS-CoV-2 pneumonia that are amenable to therapeutic interventions. Core B
is integral to supporting this goal by demonstrating strong clinical correlations to findings from the proposed
murine models.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ARDS><Acute Renal Failure with Renal Papillary Necrosis><Acute Respiratory Distress><Acute Respiratory Distress Syndrome><Address><Adult ARDS><Adult RDS><Adult Respiratory Distress Syndrome><Affect><Airway infections><Alveolar><Animal Model><Animal Models and Related Studies><Animals><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Biological><Biological Markers><Bronchioalveolar Lavage><Bronchoalveolar Lavage><Bronchoalveolar Lavage Fluid><Bronchopulmonary Lavage><COVID associated pneumonia><COVID crisis><COVID epidemic><COVID induced pneumonia><COVID pandemic><COVID pneumonia><COVID related pneumonia><COVID-19><COVID-19 associated pneumonia><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 induced pneumonia><COVID-19 pandemic><COVID-19 period><COVID-19 pneumonia><COVID-19 public health crisis><COVID-19 related pneumonia><COVID-19 viral pneumonia><COVID-19 virus><COVID-19 years><COVID19 virus><CV-19><Catabolism><Cause of Death><Cell Body><Cell model><Cells><Cellular model><Cessation of life><Chemotactic Cytokines><Clinical><CoV-2><CoV2><Cognitive Discrimination><Communicable Diseases><Coronavirus Infectious Disease 2019><Country><Critical Care><D pneumoniae><D. pneumoniae><Da Nang Lung><Data><Death><Death Certificates><Death Rate><Diplococcus pneumoniae><Discrimination><Dysfunction><Encephalopathies><Failure><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Functional disorder><Funding Opportunities><GS-5734><Goals><Grant><Grippe><Homologous Chemotactic Cytokines><Human><Immune><Immune system><Immunes><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Inflammation><Inflammatory><Influenza><Influenza A><Influenza A virus><Influenza Viruses Type A><Influenzavirus A><Infrastructure><Injury><Instruction><Intercrines><International><Intubation><Investigators><Knowledge><Liquid substance><Liver Dysfunction><Lower Respiratory Tract Infection><Lower respiratory infection><Lung><Lung Lavage><Lung Respiratory System><Lung damage><Mechanical ventilation><Mice><Mice Mammals><Microbial Superinvasion><Miscellaneous Antibiotic><Modeling><Modern Man><Modernization><Murine><Mus><Muscle><Muscle Tissue><NIAID><National Institute of Allergy and Infectious Disease><Nosocomial pneumonia><Organ><Organ failure><Orthomyxovirus Type A><Oseltamivir><Outcome><Pathway interactions><Patients><Pattern><Phenotype><Physiopathology><Pneumococcus><Pneumonia><Population><Population Study><Protein Analysis><Protocol><Protocols documentation><Publishing><Recovery><Research><Research Personnel><Research Resources><Researchers><Resolution><Resources><Respiratory Infections><Respiratory Tract Infections><S pneumoniae><S. pneumoniae><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 associated pneumonia><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 induced pneumonia><SARS-CoV-2 pandemic><SARS-CoV-2 pneumonia><SARS-CoV-2 related pneumonia><SARS-CoV-2 viral pneumonia><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SIS cytokines><Sampling><Sepsis><Sepsis and ARDS><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Shock Lung><Sorting><Stiff lung><Streptococcus pneumoniae><Systems Biology><Tamiflu><Therapeutic Intervention><Time><Type A Influenza><United States><Universities><Vasoactive Agonists><Vasoconstrictor Agents><Vasoconstrictor Drugs><Vasoconstrictors><Vasopressor Agents><Veklury><Viral><Viral Pneumonia><Virus><Wuhan coronavirus><acute kidney injury><acute respiratory distress syndrome caused by sepsis><alter microbiome><anti-microbial><antimicrobial><bacteria pathogen><bacterial pathogen><bio-markers><biologic><biologic marker><biomarker><blood infection><bloodstream infection><bronchopulmonary lavage therapy><chemoattractant cytokine><chemokine><chronic infection><clinical phenotype><clinical relevance><clinically relevant><co-infection><coinfection><community acquired pneumonia><community associated pneumonia><coronavirus disease 2019><coronavirus disease 2019 associated pneumonia><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 induced pneumonia><coronavirus disease 2019 pandemic><coronavirus disease 2019 pneumonia><coronavirus disease 2019 public health crisis><coronavirus disease 2019 related pneumonia><coronavirus disease 2019 virus><coronavirus disease associated pneumonia><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease induced pneumonia><coronavirus disease pandemic><coronavirus disease pneumonia><coronavirus disease related pneumonia><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 pneumonia><coronavirus disease-19 virus><coronavirus infectious disease-19><epigenomics><flow cytophotometry><fluid><hCoV19><healthcare-associated pneumonia><hospital acquired pneumonia><hospital associated pneumonia><influenza pneumonia><injuries><intervention therapy><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><liquid><lung failure><lung injury><lung repair><lung tissue repair><mechanical respiratory assist><mechanically ventilated><metabolism measurement><metabolomics><metabonomics><microbiome adaptation><microbiome alteration><microbiome perturbation><model of animal><mortality><mortality rate><mortality ratio><mouse model><murine model><muscular><nCoV2><pathogen><pathogenic bacteria><pathogenic virus><pathophysiology><pathway><persistent infection><pneumonia due to COVID><pneumonia due to COVID-19><pneumonia due to SARS-CoV-2><pneumonia due to coronavirus disease><pneumonia due to coronavirus disease 2019><pneumonia due to severe acute respiratory syndrome coronavirus 2><pneumonia in COVID><pneumonia in COVID-19><pneumonia in SARS-CoV-2><pneumonia in coronavirus disease><pneumonia in coronavirus disease 2019><pneumonia in severe acute respiratory syndrome coronavirus 2><pneumonia therapy><pneumonia treatment><population-based study><population-level study><programs><pulmonary><pulmonary damage><pulmonary failure><pulmonary injury><pulmonary repair><pulmonary tissue damage><pulmonary tissue injury><remdesivir><repair><repaired><resolutions><respiratory virus><response><sepsis ARDS><sepsis acute respiratory distress syndrome><sepsis and acute respiratory distress syndrome><sepsis associated acute respiratory distress syndrome><sepsis induced ARDS><sepsis induced acute respiratory distress syndrome><sepsis related acute respiratory distress syndrome><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 associated pneumonia><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 induced pneumonia><severe acute respiratory syndrome coronavirus 2 pneumonia><severe acute respiratory syndrome coronavirus 2 related pneumonia><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><studies of populations><study of the population><super infection><superinfection><transcriptomics><treat pneumonia><vasopressor><viral pathogen><virus pathogen><wet lung>